These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21315495)

  • 41. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2013 May; 63():224-30. PubMed ID: 23501108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A convenient synthesis and molecular modeling study of novel pyrazolo[3,4-d]pyrimidine and pyrazole derivatives as anti-tumor agents.
    Nassar IF; Atta-Allah SR; Elgazwy AS
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):396-405. PubMed ID: 25068728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis of novel thiazolyl-pyrimidines and their anticancer activity in vitro.
    Shi HB; Li HB; Lu KQ; Zhu XR; Hu WX; Pei W
    Arch Pharm (Weinheim); 2011 Oct; 344(10):675-83. PubMed ID: 21984017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and antiproliferative activity of 2,4-disubstituted 6-aryl-7H-pyrrolo[3,2-d]pyrimidin-7-one 5-oxides.
    Pudziuvelyte E; Ríos-Luci C; León LG; Cikotiene I; Padrón JM
    Bioorg Med Chem; 2009 Jul; 17(14):4955-60. PubMed ID: 19527934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors.
    Ibrahim DA; El-Metwally AM
    Eur J Med Chem; 2010 Mar; 45(3):1158-66. PubMed ID: 20045222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, cytotoxicity, antimicrobial and anti-biofilm activities of novel pyrazolo[3,4-b]pyridine and pyrimidine functionalized 1,2,3-triazole derivatives.
    Nagender P; Malla Reddy G; Naresh Kumar R; Poornachandra Y; Ganesh Kumar C; Narsaiah B
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2905-8. PubMed ID: 24835633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel pyrazolo[3,4-d]pyrimidine derivatives inhibit human cancer cell proliferation and induce apoptosis by ROS generation.
    Gaonkar S; Savanur MA; Nadaf AA; Najare MS; Mantur S; Garbhagudi M; Mulla SI; Khazi IAM
    Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900296. PubMed ID: 32073686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line.
    Schenone S; Bruno O; Bondavalli F; Ranise A; Mosti L; Menozzi G; Fossa P; Donnini S; Santoro A; Ziche M; Manetti F; Botta M
    Eur J Med Chem; 2004 Nov; 39(11):939-46. PubMed ID: 15501543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel Biginelli dihydropyrimidines with potential anticancer activity: a parallel synthesis and CoMSIA study.
    Prashantha Kumar BR; Sankar G; Nasir Baig RB; Chandrashekaran S
    Eur J Med Chem; 2009 Oct; 44(10):4192-8. PubMed ID: 19525040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
    Ghorab MM; Ragab FA; Heiba HI; Youssef HA; El-Gazzar MG
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6316-20. PubMed ID: 20850308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and antitumor properties of pyrazolo [3,4-D] pyrimidine derivatives.
    Witkiewicz K; Machoń Z; Mordarski M; Wieczorek J
    Pol J Pharmacol Pharm; 1987; 39(6):715-20. PubMed ID: 3503990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and anti-HSV-1 evaluation of some pyrazoles and fused pyrazolopyrimidines.
    Rashad AE; Hegab MI; Abdel-Megeid RE; Fathalla N; Abdel-Megeid FM
    Eur J Med Chem; 2009 Aug; 44(8):3285-92. PubMed ID: 19285757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and anticancer activity of some novel fused pyridine ring system.
    Elansary AK; Moneer AA; Kadry HH; Gedawy EM
    Arch Pharm Res; 2012 Nov; 35(11):1909-17. PubMed ID: 23212632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and antitumor activity of fluorocyclopentenyl-pyrimidines.
    Jeong LS; Zhao LX; Choi WJ; Pal S; Park YH; Lee SK; Chun MW; Lee YB; Ahn CH; Moon HR
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):713-6. PubMed ID: 18066886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis and biological evaluation of certain CDK2 inhibitors based on pyrazole and pyrazolo[1,5-a] pyrimidine scaffold with apoptotic activity.
    Ali GME; Ibrahim DA; Elmetwali AM; Ismail NSM
    Bioorg Chem; 2019 May; 86():1-14. PubMed ID: 30682722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Facile synthesis and in-vitro antitumor activity of some pyrazolo[3,4-b]pyridines and pyrazolo[1,5-a]pyrimidines linked to a thiazolo[3,2-a]benzimidazole moiety.
    Abdel-Aziz HA; Saleh TS; El-Zahabi HS
    Arch Pharm (Weinheim); 2010 Jan; 343(1):24-30. PubMed ID: 19921685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, characterization, antiamoebic activity and cytotoxicity of new pyrazolo[3, 4-d]pyrimidine-6-one derivatives.
    Hayat F; Salahuddin A; Azam A
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):472-9. PubMed ID: 21054147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors.
    Dreassi E; Zizzari AT; Mori M; Filippi I; Belfiore A; Naldini A; Carraro F; Santucci A; Schenone S; Botta M
    Eur J Med Chem; 2010 Dec; 45(12):5958-64. PubMed ID: 20970221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of new pyrazole derivatives and their anticancer evaluation.
    Nitulescu GM; Draghici C; Missir AV
    Eur J Med Chem; 2010 Nov; 45(11):4914-9. PubMed ID: 20728965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.
    El-Gamal MI; Sim TB; Hong JH; Cho JH; Yoo KH; Oh CH
    Arch Pharm (Weinheim); 2011 Mar; 344(3):197-204. PubMed ID: 21384419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.